Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas

Within tumours, many non‐neoplastic cells such as fibroblasts, endothelial cells, and macrophages assist tumour growth by producing various growth factors and pro‐angiogenic cytokines. Various tumour‐derived molecules drive tumour‐associated macrophages towards an anti‐inflammatory phenotype (M2) and thus promoting tumour growth. Here we investigated microglia/macrophage differentiation in glioma tissues by means of immunostaining of paraffin‐embedded glioma samples. The number of microglia/macrophages with positive staining for CD163 and CD204, which are believed to be markers for M2 macrophages, was correlated with the histological grade of the gliomas. The ratio of M2 macrophages in the tumour‐associated microglia/macrophages was also associated with the histological grade. Culture supernatant from the glioma cell line can stimulate macrophages to develop into the M2 phenotype in vitro. Macrophage colony‐stimulating factor (M‐CSF), which strongly induces M2 polarization of macrophages, was significantly correlated with histological malignancy and with the proportion of M2 microglia/macrophages in vivo. In addition, the proportion of M2 microglia/macrophages and M‐CSF expression in tumour cells correlated well with proliferation of glioblastoma cells. These results suggest that tumour‐derived M‐CSF induces a shift of microglia/macrophages towards the M2 phenotype, which influences tumour growth. Evaluation of the proportion of M2 microglia/macrophages and M‐CSF expression in tumour tissue would be useful for assessment of microglia/macrophage proliferative activity and the prognosis of patients with gliomas. Copyright © 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  P. Guyre,et al.  Cross‐linking of FcγR triggers shedding of the hemoglobin‐haptoglobin scavenger receptor CD163 , 2004, Journal of leukocyte biology.

[2]  M. Bissell.  Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene ExpressionMartinez FO, Gordon S, Locati M, et al (Univ of Milan, Italy; Univ of Oxford, England) J Immunol 177:7303–7311, 2006§ , 2008 .

[3]  R. Alterman,et al.  Colony stimulating factor-1 expression in human glioma , 1994, Molecular and chemical neuropathology.

[4]  T. Shono,et al.  Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  Alberto Mantovani,et al.  Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. , 2006, European journal of cancer.

[6]  Frank Brombacher,et al.  Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.

[7]  M. Caldwell,et al.  Temporal expression of different pathways of 1-arginine metabolism in healing wounds. , 1990, Journal of immunology.

[8]  X. Ji,et al.  Interaction between M-CSF and IL-10 on productions of IL-12 and IL-18 and expressions of CD14, CD23, and CD64 by human monocytes. , 2004, Acta pharmacologica Sinica.

[9]  B. Aggarwal,et al.  A Previously Unrecognized Protein-Protein Interaction between TWEAK and CD163: Potential Biological Implications1 , 2007, The Journal of Immunology.

[10]  M. Platten,et al.  Malignant glioma biology: Role for TGF‐β in growth, motility, angiogenesis, and immune escape , 2001 .

[11]  D. Mosser,et al.  The many faces of macrophage activation , 2003, Journal of leukocyte biology.

[12]  L. Kobzik,et al.  Disparate Regulation and Function of the Class A Scavenger Receptors SR-AI/II and MARCO1 , 2005, The Journal of Immunology.

[13]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[14]  M. Tada,et al.  Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction. , 1994, Journal of neurosurgery.

[15]  J. Pollard.  Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[16]  A. Korshunov,et al.  Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases. , 1999, Journal of clinical pathology.

[17]  T. K. van den Berg,et al.  Human peritoneal macrophages show functional characteristics of M‐CSF‐driven anti‐inflammatory type 2 macrophages , 2007, European journal of immunology.

[18]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[19]  G. Soma,et al.  The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. , 2003, Anticancer research.

[20]  C. Stegen,et al.  Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10 , 1998, Journal of Neuro-Oncology.

[21]  S. Gordon,et al.  Ovarian Cancer Cells Polarize Macrophages Toward A Tumor-Associated Phenotype1 , 2006, The Journal of Immunology.

[22]  P. Rieckmann,et al.  Microglial/macrophage expression of interleukin 10 in human glioblastomas , 1999, International journal of cancer.

[23]  S. Ferrone,et al.  HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? , 2005, Cancer research.

[24]  M. Kurrer,et al.  Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. , 2001, The American journal of pathology.

[25]  S. Tsutsui,et al.  Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. , 2005, Oncology reports.

[26]  Jiasen Cheng,et al.  Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. , 2007, Blood.

[27]  W. Gause,et al.  Alternatively activated macrophages in helminth infections. , 2007, Current opinion in immunology.

[28]  N. Araki,et al.  AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[29]  R. Palmqvist,et al.  High Macrophage Infiltration along the Tumor Front Correlates with Improved Survival in Colon Cancer , 2007, Clinical Cancer Research.

[30]  S. Davidson,et al.  Lack of association between in vitro clonogenic growth of human cervical carcinoma and tumour stage, differentiation, patient age, host cell infiltration or patient survival , 1992, International journal of cancer.

[31]  Y. Wan,et al.  Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy , 2007, Clinical Cancer Research.

[32]  L. Shulman.  Elevated Expression of the Oncogene c-fms and Its Ligand, the Macrophage Colony-Stimulating Factor-1, in Cervical Cancer and the Role of Transforming Growth Factor-β1 in Inducing c-fms Expression , 2008 .

[33]  Christine E. Brown,et al.  619. Tumor-Derived Chemokine MCP-1/CCL2 Is Sufficient for Mediating Tumor Tropism of Adoptively Transferred T-Cells , 2006 .

[34]  P. De Baetselier,et al.  Alternatively activated macrophages in protozoan infections. , 2007, Current opinion in immunology.

[35]  S. Goerdt,et al.  Other functions, other genes: alternative activation of antigen-presenting cells. , 1999, Immunity.

[36]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[37]  S. Goerdt,et al.  Differences in angiogenic potential of classically vs alternatively activated macrophages. , 1997, Immunobiology.

[38]  J. Flamm,et al.  Tumorassoziiertes mononukleäres Zellinfiltrat und Rezidivneigung beim oberflächlichen Urothelkarzinom der Harnblase , 1986 .

[39]  T. Wheeler,et al.  Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. , 2000, Cancer research.

[40]  David J. Yang,et al.  The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. , 2006, Neuro-oncology.

[41]  A. Heimberger,et al.  A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients. , 2007, Cancer research.

[42]  D. Munn,et al.  Pattern of Recruitment of Immunoregulatory Antigen-Presenting Cells in Malignant Melanoma , 2003, Laboratory Investigation.

[43]  Noam Brown,et al.  The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.

[44]  Barbara Bottazzi,et al.  Autocrine Production of IL-10 Mediates Defective IL-12 Production and NF-κB Activation in Tumor-Associated Macrophages1 , 2000, The Journal of Immunology.

[45]  Douglas T. Golenbock,et al.  Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages , 2006, Proceedings of the National Academy of Sciences.

[46]  C. Lewis,et al.  Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. , 2005, The American journal of pathology.

[47]  H. Drexler,et al.  Specificity and sensitivity of polymerase chain reaction (PCR) in comparison with other methods for the detection of mycoplasma contamination in cell lines. , 1993, Journal of immunological methods.

[48]  B. Berwin,et al.  Scavenger receptor-A-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression. , 2007, Cancer research.

[49]  H. Gascan,et al.  Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. , 2007, Blood.

[50]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[51]  W. Paulus,et al.  Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. , 1995, The American journal of pathology.

[52]  S. Gordon,et al.  Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale. , 2001, The Journal of clinical investigation.

[53]  J. Pollard,et al.  Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.

[54]  T. Langmann,et al.  Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro‐ and antiinflammatory stimuli , 2000, Journal of leukocyte biology.

[55]  P. Allavena,et al.  Tumor-Associated Macrophages and Dendritic Cells as Prototypic Type II Polarized Myeloid Populations , 2003, Tumori.